Broadfin Capital, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 31 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$4,745,000250,0000.75%
Other shareholders

There were no reported owners of XERIS PHARMACEUTICALS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of XERIS PHARMACEUTICALS INC shareholders